APA (7th ed.) Citation

M, V., L, K., R, A., K, M., R, H., D, G., . . . R, S. (2013). Radiological-pathological analysis of WHO, RECIST, EASL, mRECIST and DWI: Imaging analysis from a prospective randomized trial of Y90 ± sorafenib. Hepatology (Baltimore, Md.), 58(5), 1655. https://doi.org/10.1002/hep.26487

Chicago Style (17th ed.) Citation

M, Vouche, et al. "Radiological-pathological Analysis of WHO, RECIST, EASL, MRECIST and DWI: Imaging Analysis from a Prospective Randomized Trial of Y90 ± Sorafenib." Hepatology (Baltimore, Md.) 58, no. 5 (2013): 1655. https://doi.org/10.1002/hep.26487.

MLA (9th ed.) Citation

M, Vouche, et al. "Radiological-pathological Analysis of WHO, RECIST, EASL, MRECIST and DWI: Imaging Analysis from a Prospective Randomized Trial of Y90 ± Sorafenib." Hepatology (Baltimore, Md.), vol. 58, no. 5, 2013, p. 1655, https://doi.org/10.1002/hep.26487.